Skip to main content
Clinical Trials/ITMCTR2000003722
ITMCTR2000003722Not yet recruitingPhase 1

Clinical observation of Nianmo Decoction in preventing recurrence of non muscle invasive bladder cancer through PDL1 mediated immune pathway

Yueyang Hospital of Integrated Traditional Chinese and Western medicine, Shanghai University of Traditional Chinese Medicine0 sitesStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 1
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional study

Eligibility Criteria

Sex
All

Inclusion Criteria

  • 1. 18 years old <= age <= 85 years old;
  • 2. Non invasive bladder cancer (TA: non-invasive papillary carcinoma; T1: tumor invasion of subepithelial connective tissue) after resection of urethral bladder tumor;
  • 3. According to the syndrome type of traditional Chinese medicine, the diagnosis of Damp heat accumulation;
  • 4. Consent to participate in the trial and sign informed consent.

Exclusion Criteria

  • 1. Postoperative pathology showed bladder tumor with muscle infiltration;
  • 2. Combined with cardiovascular, liver, kidney and hematopoietic system and other serious diseases;
  • 3. Those who participated in or are participating in other clinical trials 3 months ago;
  • 4. The presence of familial genetic diseases or other diseases that may affect this trial;
  • 5. The researcher assessed that it was not suitable to participate in this study.

Investigators

Sponsor
Yueyang Hospital of Integrated Traditional Chinese and Western medicine, Shanghai University of Traditional Chinese Medicine

Similar Trials